Sanifit Seals Booming Acquisition Year for Spanish Life Sciences
The takeover of the Spanish firm Sanifit by Vifor Pharma in Switzerland marks a high…
The takeover of the Spanish firm Sanifit by Vifor Pharma in Switzerland marks a high…
New, more targeted treatments are on the horizon for the rare autoimmune disease ANCA-associated vasculitis,…
The EU recently added two drugs to its list of approved Covid-19 treatments. Yet with…
Painstaking and expensive procedures are required to produce human cells for use in research and…
As this month’s COP26 United Nations climate summit highlighted the climate change emergency, venture capital…
Vaccines for Covid-19 are rolling out all over the world, but their protection is threatened…
With many targeted protein degraders hitting the clinic, lucrative collaborations and acquisitions are being signed…
German life sciences heavyweight Evotec raised around €376M ($435M) in its US debut on the…
Despite vast amounts of funding entering the cell and gene therapy field, the manufacture of…
DNA manufacturing was a hot topic in biotech investments in October, with immuno-oncology and insect…
Touchlight Genetics and DNA Script have closed major venture financing rounds in the last month…
Last week, the French vaccine maker Valneva announced promising phase III trial results of its…